Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03674567
Title Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors FLX Bio, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center ACTIVE_NOT_RECRUITING Gilbert Arizona 85234 United States Details
City of Hope ACTIVE_NOT_RECRUITING Duarte California 91010 United States Details
University of California, Los Angeles JCCC Clinical Research Unit ACTIVE_NOT_RECRUITING Los Angeles California 90024 United States Details
Yale Cancer Center ACTIVE_NOT_RECRUITING New Haven Connecticut 06510 United States Details
Georgetown - Lombardi Comprehensive Cancer Center ACTIVE_NOT_RECRUITING Washington District of Columbia 20007 United States Details
Comprehensive Hematology and Oncology, LLC ACTIVE_NOT_RECRUITING Saint Petersburg Florida 33709 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Emory Winship Cancer Institute COMPLETED Atlanta Georgia 30322 United States Details
University of Chicago ACTIVE_NOT_RECRUITING Chicago Illinois 60637 United States Details
University of Louisville Hospital/James Graham Brown Cancer Center ACTIVE_NOT_RECRUITING Louisville Kentucky 40202 United States Details
Johns Hopkins University ACTIVE_NOT_RECRUITING Baltimore Maryland 21231 United States Details
Dana-Farber Cancer Institute ACTIVE_NOT_RECRUITING Boston Massachusetts 02215 United States Details
University of Michigan ACTIVE_NOT_RECRUITING Ann Arbor Michigan 48109 United States Details
Quantum Santa Fe COMPLETED Santa Fe New Mexico 87505 United States Details
New York Presbyterian Hospital-Columbia University Medical Center ACTIVE_NOT_RECRUITING New York New York 10032 United States Details
Carolina BioOncology Institute COMPLETED Huntersville North Carolina 28078 United States Details
Mary Crowley Cancer Research Center ACTIVE_NOT_RECRUITING Dallas Texas 75230 United States Details
The University of Texas MD Anderson Cancer Center ACTIVE_NOT_RECRUITING Houston Texas 77030 United States Details
University of Washington RECRUITING Seattle Washington 98195 United States Details
Austin Hospital COMPLETED Heidelberg Victoria 3084 Australia Details
Linear Clinical Research Limited COMPLETED Nedlands Western Australia 6009 Australia Details
Queen Mary Hospital - Lymphoma RECRUITING High West Hong Kong Details
Queen Mary Hospital RECRUITING High West Hong Kong Details
Prince of Wales Hospital RECRUITING Shatin Hong Kong Details
Inje University Busan Paik Hospital RECRUITING Busan 47392 Korea, Republic of Details
Chungbuk National University Hospital RECRUITING Chungbuk 28644 Korea, Republic of Details
Seoul National University Bundang Hospital RECRUITING Gyeonggi-do 13620 Korea, Republic of Details
Seoul National University RECRUITING Seoul 03080 Korea, Republic of Details
Severance Hospital, Yonsei University Health System RECRUITING Seoul 03722 Korea, Republic of Details
Asan Medical Center RECRUITING Seoul 05505 Korea, Republic of Details
Samsung Medical Center RECRUITING Seoul 06351 Korea, Republic of Details
Ulsan University Hospital WITHDRAWN Ulsan 44033 Korea, Republic of Details
National Cheng Kung University Hospital RECRUITING Tainan 70403 Taiwan Details
Chi Mei Meidcal Center RECRUITING Tainan 71004 Taiwan Details
National Taiwan University Hospital RECRUITING Taipei 10002 Taiwan Details
Taipei Veterans General Hospital RECRUITING Taipei 11217 Taiwan Details
King Chulaongkorn Memorial Hospital RECRUITING Bangkok 10330 Thailand Details
Ramathibodi Hospital RECRUITING Bangkok 10400 Thailand Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field